A FedEx Corp. subsidiary agreed to pay a $2 million civil penalty to settle a Justice Department investigation into the company’s handling of controlled substances.
The U.S. Attorney for the Eastern District of Wisconsin announced Aug. 23 its settlement agreement with Capital Returns Inc., doing business as Genco Pharmaceuticals Services, to resolve alleged Controlled Substance Act (CSA) violations. The company, renamed FedEx Supply Chain after FedEx Corp. acquired it in January 2015, specializes in destroying pharmaceutical returns and is authorized to receive and distribute controlled substances by the Drug Enforcement Administration.
The Justice Department settlement is one of the latest ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.